Sex influences transmission of the supratype associated with the C2 deficiency allele: a possible mechanism for the maintenance of heterozygosity and disease susceptibility.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 3980253)

Published in Hum Immunol on March 01, 1985

Authors

P H Kay, R L Dawkins, F T Christiansen

Articles by these authors

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet (2002) 5.48

Nomenclature for the major histocompatibility complexes of different species: a proposal. Immunogenetics (1990) 3.53

Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax (1983) 3.00

Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66

Fatigue testing median sternotomy closures. Eur J Cardiothorac Surg (2001) 2.27

Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression. N Engl J Med (1973) 2.25

Disease associations with complotypes, supratypes and haplotypes. Immunol Rev (1983) 1.87

Central MHC genes, IgA deficiency and autoimmune disease. Immunol Today (1990) 1.81

Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation (1999) 1.81

The P5 multicopy gene family in the MHC is related in sequence to human endogenous retroviruses HERV-L and HERV-16. Immunogenetics (1999) 1.71

Experimental myositis associated with hypersensitivity to muscle. J Pathol Bacteriol (1965) 1.59

Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol (1992) 1.48

Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun (2005) 1.47

Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol (1993) 1.39

Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia. Clin Exp Immunol (1975) 1.38

Haemodynamic performance of a 16-mm Carbomedics aortic prosthesis. Eur J Cardiothorac Surg (1997) 1.37

Experience with the modified Blalock-Taussig operation using polytetrafluoroethylene (Impra) grafts. Br Heart J (1983) 1.35

Laboratory tests in clinical immunology: a critique. Am J Med (1980) 1.34

Autoimmunity in ocular and generalised myasthenia gravis. J Neuroimmunol (1981) 1.32

An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics (1992) 1.32

The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens (2004) 1.31

The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics (2000) 1.29

Antibodies to skeletal muscle demonstrated by immunofluorescence in experimental autoallergic myositis. Clin Exp Immunol (1971) 1.28

Complement allotyping in SLE: association with C4A null. Aust N Z J Med (1983) 1.24

SNP profile within the human major histocompatibility complex reveals an extreme and interrupted level of nucleotide diversity. Genome Res (2000) 1.24

Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes. Immunogenetics (1986) 1.23

Genetic control of suppressor lymphocyte function in myasthenia gravis: relationship of impaired suppressor function to HLA-B8/DRW3 and cold reactive lymphocytotoxic antibodies. Clin Immunol Immunopathol (1979) 1.23

Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol (1983) 1.23

Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS (1992) 1.20

HLA and complement allotypes in Type 1 (insulin-dependent) diabetes. Diabetologia (1983) 1.20

Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes. J Exp Med (1993) 1.18

Immune function in ankylosing spondylitis: apparent relationship between streptococcal responses and HLA B27. J Rheumatol Suppl (1977) 1.17

A biomechanical study of median sternotomy closure techniques. Eur J Cardiothorac Surg (1999) 1.17

Extensive nucleotide variability within a 370 kb sequence from the central region of the major histocompatibility complex. Gene (1999) 1.12

Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics (1992) 1.11

B-cell target DNA quantity is a critical factor in the interpretation of B-cell clonality by PCR. Pathology (1997) 1.11

An analysis of variation in the long-range genomic organization of the human major histocompatibility complex class II region by pulsed-field gel electrophoresis. Genomics (1989) 1.11

Chordal rupture. I: aetiology and natural history. Br Heart J (1983) 1.11

Cancer in connective tissue disease. Arthritis Rheum (1982) 1.11

Exposure to blood borne infections in health care workers. Med J Aust (1992) 1.10

Use of the B27 test in the diagnosis of ankylosing spondylitis: a statistical evaluation. Arthritis Rheum (1981) 1.08

A new polymorphic and multicopy MHC gene family related to nonmammalian class I. Immunogenetics (1994) 1.07

Family studies of IgA deficiency. Immunogenetics (1985) 1.07

Hepatocellular carcinoma: presentation with vertebral metastases and radicular compression. Cancer (1972) 1.07

Long-term results of Ionescu-Shiley valve in the tricuspid position. Ann Thorac Surg (1991) 1.06

Retracted Characterization of the alternate allelic forms of human PAX7. Mamm Genome (2000) 1.05

The diagnostic significance of autoantibodies to the acetylcholine receptor. J Neuroimmunol (1982) 1.05

Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet (1980) 1.05

Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods (1988) 1.04

HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis. Br Med J (Clin Res Ed) (1983) 1.04

Quality assessment program for genotypic antiretroviral testing improves detection of drug resistance mutations. J Clin Microbiol (2003) 1.04

Acute abdominal complications of systemic lupus erythematosus. Br J Surg (1978) 1.03

Detection of KIR2DL4 alleles by sequencing and SSCP reveals a common allele with a shortened cytoplasmic tail. Tissue Antigens (2000) 1.03

Murine candidiasis: sex differences in the severity of tissue lesions are not associated with levels of serum C3 and C5. Immunol Cell Biol (1991) 1.02

A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB3,4,5. Tissue Antigens (2004) 1.02

Some disease-associated ancestral haplotypes carry a polymorphism of TNF. Hum Immunol (1989) 1.00

Autoantibodies and HLA antigens in ocular, generalized and penicillamine-induced myasthenia gravis. Ann N Y Acad Sci (1981) 0.99

Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum Immunol (1990) 0.99

Extensive deletions and insertions in different MHC supratypes detected by pusled field gel electrophoresis. J Exp Med (1988) 0.99

Different evolutionary histories in two subgenomic regions of the major histocompatibility complex. Genome Res (1999) 0.99

Open lung biopsy in patients with diffuse pulmonary shadowing. Thorax (1985) 0.98

Cross-reactivity of anti-acetylcholine receptor autoantibodies. Muscle Nerve (1981) 0.98

Immune function in ankylosing spondylitics and their relatives: influence of disease and HLA B27. Clin Exp Immunol (1978) 0.98

Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies. Am J Med (1977) 0.98

Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens (2005) 0.98

Evidence that cytosine residues within 5'-CCTGG-3' pentanucleotides can be methylated in human DNA independently of the methylating system that modifies 5'-CG-3' dinucleotides. DNA Cell Biol (2000) 0.97

Characterisation of immunofluorescent heterophile antibodies which may be confused with autoantibodies. J Clin Pathol (1977) 0.97

Congenital double chambered left ventricle treated by exclusion of accessory chamber. Br Heart J (1983) 0.97

Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles. J Clin Pathol (1986) 0.96

Differences in gene copy number carried by different MHC ancestral haplotypes. Quantitation after physical separation of haplotypes by pulsed field gel electrophoresis. J Exp Med (1990) 0.96

Positive allergy prick tests associated with bronchial histamine responsiveness in an unselected population. J Allergy Clin Immunol (1986) 0.96

Direct observation of the gene organization of the complement C4 and 21-hydroxylase loci by pulsed field gel electrophoresis. J Exp Med (1989) 0.95

MICA, MICB, and MHC beta block matching in bone marrow transplantation: relevance to transplantation outcome. Hum Immunol (2006) 0.95

Maternal KIR repertoire is not associated with recurrent spontaneous abortion. Hum Reprod (2004) 0.95

DR-positive maternal engrafted T cells in a severe combined immunodeficiency patient without graft-versus-host disease. Transplantation (1980) 0.95

The implications of intergenic polymorphism for major histocompatibility complex evolution. Genetics (2000) 0.95

Epidemiology of late presentation of HIV infection in Western Australia. Med J Aust (1992) 0.95

Coevolution of PERB11 (MIC) and HLA class I genes with HERV-16 and retroelements by extended genomic duplication. J Mol Evol (1999) 0.95

HLA in systemic lupus erythematosus: influence on severity. Tissue Antigens (1978) 0.94